Featured Article
Patient Connectivity Benefits Familial Chylomicronemia Syndrome
Patients with familial chylomicronemia syndrome who were actively connected were also 3 times as likely to report "high" or "extremely high" motivation in managing their own health.
Latest Features
Breathing New Life Into COPD and Asthma Therapy With Statins
Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.
PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis
Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.
Statins Limit Vaccine Efficacy of Influenza Strain
Statin use modified vaccine effectiveness and influenza risk for A(H3N2) infection but not for A(H1N1).
Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C
Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.
Considering Cardiovascular Risks of Antidiabetic Drugs
A review of current antidiabetic drug treatments available and their individual cardiovascular risk profiles.
PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost
PCSK9 inhibitors may offer hope to patients with familial hypercholesterolemia who cannot tolerate or achieve goal LDL-C levels with statins.
LATEST NEWS
Patient Connectivity Benefits Familial Chylomicronemia Syndrome
Patients with familial chylomicronemia syndrome who were actively connected were also 3 times as likely to report "high" or "extremely high" motivation in managing their own health.
Idiopathic inflammatory myositis linked to statin exposure
In a case-control study, patients with histologically-confirmed idiopathic inflammatory myositis were more likely to report exposure to statin medications than population-matched controls.
Statin Prescribing Has Increased With Automated Patient Dashboard
Modest increase in statin prescribing with automated dashboard using active choice framing for primary care physicians.
Unfavorable Prepregnancy Lipid Levels Linked to Low Parity
Higher prepregnancy triglyceride levels and triglyceride high-density lipoprotein cholesterol ratios were linked to increased risk for one lifetime pregnancy.
Preeclampsia, Gestational Hypertension Increases CVD Risk Later in Life
Women with preeclampsia or gestational hypertension during their first pregnancy were more likely to report increased rates of subsequent chronic hypertension, type 2 diabetes, and hypercholesterolemia compared with women who were normotensive.
Statin Use and Cardiovascular Risk Perception Varies Among Races
African American patients were less likely than white patients to be treated with any statin and at the guideline-recommended intensity.
Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes
To understand the mechanism underlying the benefit of fenofibrate on vascular complications in patients with type 2 diabetes, investigators assessed carotid intima thickness as a marker of subclinical atherosclerosis.
Many AKI Reports in FAERS Linked to Drugs Not Recognized as Nephrotoxic
According to the authors, this is the first study to identify medications most commonly reported for a specific adverse reaction using this database.
Increased Arterial Stiffness Observed in Patients With Systemic Lupus Erythematosus
Patients with systemic lupus erythematosus exhibit increased central arterial stiffness compared with a healthy control population.
LDL-C Reduction Examined With Different Evolocumab Dosing Regimens
For this study, researchers investigated the pharmacodynamics of evolocumab in two Phase 2 placebo-controlled studies (MENDEL and LAPLACE-TIMI 57) in order to determine which dosing regimens provided the most consistent LDL-C reduction.
The Cardiology Advisor Articles
- AHA/ACC: Updated Management Guidelines for Adult Congenital Heart Disease
- USPSTF Does Not Recommend Afib Screening in Asymptomatic Patients
- American Heart Association Urges Screen Time Limits for Youth
- Patient Connectivity Benefits Familial Chylomicronemia Syndrome
- FDA Approves First Drug Under the Competitive Generic Therapy Pathway
- Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease
- Tricuspid Regurgitation Velocity Unreliable Indicator of Pulmonary Hypertension
- Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes
- The Challenge of Compassion in Modern Healthcare Settings
- Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib
- Extreme Preterm Infants at Risk for Early Age High Blood Pressure
- Anemia Identified as Risk Factor for Contrast-Induced Acute Kidney Injury
- Case: Hypertensive Crisis Following Use of Armodafinil + MAOI
- Triple Combination Pill Can Improve Blood Pressure Control
- Labetalol Use Higher in Patients With Preeclampsia and Asthma